Skip to main content

Table 1 Characteristics of users and non-users of CAM and prayer-for-health

From: Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy

  

Included prayer-for-health

Excluded prayer-for-health

Prayer-for-health only

Characteristics

All participants N = 546

CAM users N = 386

Non-CAM users N = 160

X2

CAM users N = 361

Non-CAM users N = 185

X2

Users N = 159

Non-users N = 387

X2

n (%)

n (%)

n (%)

p-value

n (%)

n (%)

p-value

n (%)

n (%)

 

Age Mean ± SD 51.6 ± 9.2

          

 30–39

58 (10.6)

45 (11.7)

13 (8.1)

0.52

40 (11.1)

18 (9.7)

0.97

18 (11.3)

40 (10.3)

0.84

 40–49

155 (28.4)

109 (28.2)

46 (28.8)

 

102 (28.3)

53 (28.6)

 

43 (27.0)

112 (28.9)

 

 50–59

235 (43.0)

167 (43.3)

68 (42.5)

 

154 (42.7)

81 (43.8)

 

72 (45.3)

163 (42.1)

 

 60 and above

98 (18.0)

65 (16.8)

33 (20.6)

 

65 (18.0)

33 (17.8)

 

26 (16.4)

72 (18.6)

 

Ethnicity

          

 Malay

246 (45.1)

179 (46.4)

67 (41.9)

0.47

164 (45.4)

82 (44.3)

0.18

98 (61.6)

148 (38.2)

<.001**

 Chinese

207 (37.9)

141 (36.5)

66 (41.2)

 

136 (37.7)

71 (38.4)

 

34 (21.4)

173 (44.7)

 

 Indian

80 (14.7)

54 (14.0)

26 (16.2)

 

49 (13.6)

31 (16.8)

 

24 (15.1)

56 (14.5)

 

 Others

13 (2.4)

12 (3.1)

1 (0.6)

 

12 (3.3)

1 (0.5)

 

3 (1.9)

10 (2.6)

 

Education level

          

 Primary/lower

119 (21.8)

68 (17.6)

51 (31.9)

<.001**

65 (18.0)

54 (29.2)

<.001*

27 (17.0)

92 (23.8)

0.19

 Secondary

291 (53.3)

203 (52.6)

88 (55.0)

 

188 (52.1)

103 (55.7)

 

88 (55.3)

203 (52.5)

 

 Tertiary

136 (24.9)

115 (29.8)

21 (13.1)

 

108 (29.9)

28 (15.1)

 

44 (27.7)

92 (23.8)

 

Marital status

          

 Single

60 (11.0)

44 (11.4)

16 (10.0)

0.63

43 (11.9)

17 (9.2)

0.34

22 (13.8)

38 (9.8)

0.17

 Ever married

486 (89.0)

342 (88.6)

144 (90.0)

 

318 (88.1)

168 (90.8)

 

137 (86.2)

349 (90.2)

 

Household income/month

          

 ≤RM 3000(≈944 USD)

393 (72.0)

253 (65.5)

140 (87.5)

<.001**

239 (66.2)

151 (83.2)

<.001*

96 (60.4)

297 (76.7)

<.001**

 >RM 3000(≈944 USD)

153 (28.0)

133 (34.5)

20 (12.5)

 

122 (33.8)

31 (16.8)

 

63 (39.6)

90 (23.3)

 

Staging of disease

          

 Early

338 (61.9)

228 (59.1)

110 (68.8)

0.03*

212 (58.7)

126 (68.1)

0.03*

82 (51.6)

256 (66.1)

<.001**

 Advanced

208 (38.1)

158 (40.9)

50 (31.2)

 

149 (41.3)

59 (31.9)

 

77 (48.4)

131 (33.9)

 

Menopausal status

          

 Pre menopause

249 (45.6)

184 (47.7)

65 (40.6|)

0.13

169 (46.8)

80 (43.2)

0.43

81 (50.9)

168 (43.4)

0.11

 Post menopause

297 (54.4)

202(52.3)

95 (59.4)

 

192 (53.2)

105 (56.8)

 

78 (49.1)

219 (56.6)

 

Chemotherapy regimen

          

 Docetaxel

120 (22.0)

91 (23.6)

29 (18.1)

0.16

86 (23.8)

34 (18.4)

0.15

37 (23.3)

83 (21.4)

0.64

 FEC/FAC/CMF/AC

426 (78.0)

295 (76.4)

131 (81.9)

 

275 (76.2)

151 (81.6)

 

122 (76.7)

304 (78.6)

 

Chemotherapy cycle

          

 2, 3 and 4

368 (67.4)

258 (66.8)

110 (68.8)

0.66

238 (65.9)

130 (70.3)

0.31

109 (68.6)

259 (66.9)

0.71

 5 and 6

178 (32.6)

128 (33.2)

50 (31.2)

 

123 (34.1)

55 (29.7)

 

50 (31.4)

128 (33.1)

 

Chemotherapy adherence

          

 Postponed

45 (8.2)

41 (10.6)

4 (2.5)

<.001**

39 (10.8)

6 (3.2)

<.001**

10 (6.3)

35 (9.0)

0.28

 On schedule

501 (91.8)

345 (89.4)

156 (97.5)

 

322 (89.2)

179 (96.8)

 

149 (93.7)

352 (91.0)

 
  1. **p < 0.001.
  2. *p < 0.05.